- Mutual Funds
- ICICI Prudential Mutual Fund
- ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth
₹ 39.88
NAV (Apr 25)
Sectoral / Thematic - Pharma And Healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).
The pharma benchmark index itself has been a material underperformer over an extended time frame.
Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.
Scheme Information
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Expense Ratio | 1.11 % |
Launched 6Y ago | 2018-07-13 |
AUM in Crores | 4914.6 |
ISIN | INF109KC1GH2 |
Lock-in (days) | No Lock-in |
Benchmark | BSE Healthcare Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation | 16.1 |
Beta | 0.9 |
Sharpe Ratio | 1 |
Asset allocation and Holdings
Top Stock Holdings
Sun Pharmaceutical Industries Ltd.
15.28%Dr. Reddy's Laboratories Ltd.
6.82%Cipla Ltd.
6.75%Aurobindo Pharma Ltd.
5.44%Others
4.79%
Allocation by Sector
Healthcare
89.02%Chemicals
5.77%Insurance
2.82%Services
1.43%
Comparison with Equity Funds
| Fund Name | Fund Size | |
|---|---|---|
₹ 49,131 cr | ||
₹ 93,440 cr | ||
₹ 64,962 cr | ||
₹ 27,730 cr | ||
₹ 23,379 cr |
